RIPE-KG · Version 1.1.0 · Resource

ripekg:retraction-notice/67439

https://w3id.org/ripe/ripe-kg/retraction-notice/67439
SubjectPredicateObject
ripekg:evaluation/RIPEA084C6EAC9724305F prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA0C83AF9CE6274D42 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA188DF79DAC4D30E2 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA1CF9367F3C1B1AFC prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA22B2228793442254 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA3DB7B5186353EACB prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA4BED4D9BD987577D prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA533765E11F40F1A0 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA534C4E03EC302AE0 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA55912887A066C004 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA5D88C2D2406A5D02 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA624ED2A466C40B70 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA69C9C09037F4A7D7 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA80149EADA6466949 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA83B5CB372F4B48C3 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA84BEB5719212517B prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA85E75680E0A580E5 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA8DB1A5C7D4B2BCF0 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA95D9EF8B2CE9BCA4 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEA9FB7C0468A11295E prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEAA8CC2475945829CC prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEAC29393890CA84E8D prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEAC60164BBD59BB4A3 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEAF3FB72DC47E629EA prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:evaluation/RIPEAFB2FF36932B98401 prov:used ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prism:doi 10.1080/09513590.2020.1841983
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prism:publicationDate 2020-11-11
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prism:publicationName Gynecological Endocrinology
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial dcterms:publisher ripekg:publisher/RIPEP08117F3F6484319BTaylor and Francis
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial dcterms:title Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial http://purl.org/spar/cito/retracts ripekg:work/10.1080%2F09513590.2017.1290071
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial rdf:type http://purl.org/spar/fabio/RetractionNotice
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial rdf:type rdfs:Resource
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial rdf:type owl:Thing
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial rdf:type ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial rdf:type ripe:RetractionNoticeRetraction notice
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial rdf:type tido:Evidence
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial rdf:type tido:PieceOfInformation
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial owl:sameAs https://semopenalex.org/work/W4250239878
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasAttributedTo ripekg:source/retraction-watchRetraction Watch
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasAttributedTo ripekg:source/retraction-watchRetraction Watch Database
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA084C6EAC9724305F
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA0C83AF9CE6274D42
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA188DF79DAC4D30E2
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA1CF9367F3C1B1AFC
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA22B2228793442254
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA3DB7B5186353EACB
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA4BED4D9BD987577D
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA533765E11F40F1A0
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA534C4E03EC302AE0
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA55912887A066C004
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA5D88C2D2406A5D02
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA624ED2A466C40B70
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA69C9C09037F4A7D7
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA80149EADA6466949
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA83B5CB372F4B48C3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA84BEB5719212517B
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA85E75680E0A580E5
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA8DB1A5C7D4B2BCF0
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA95D9EF8B2CE9BCA4
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA9FB7C0468A11295E
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEAA8CC2475945829CC
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEAC29393890CA84E8D
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEAC60164BBD59BB4A3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEAF3FB72DC47E629EA
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEAFB2FF36932B98401
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA084C6EAC9724305F
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA0C83AF9CE6274D42
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA188DF79DAC4D30E2
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA1CF9367F3C1B1AFC
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA22B2228793442254
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA3DB7B5186353EACB
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA4BED4D9BD987577D
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA533765E11F40F1A0
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA534C4E03EC302AE0
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA55912887A066C004
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA5D88C2D2406A5D02
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA624ED2A466C40B70
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA69C9C09037F4A7D7
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA80149EADA6466949
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA83B5CB372F4B48C3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA84BEB5719212517B
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA85E75680E0A580E5
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA8DB1A5C7D4B2BCF0
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA95D9EF8B2CE9BCA4
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA9FB7C0468A11295E
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEAA8CC2475945829CC
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEAC29393890CA84E8D
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEAC60164BBD59BB4A3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEAF3FB72DC47E629EA
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial prov:wasMemberOf ripekg:research-integrity-assessment/RIPEAFB2FF36932B98401
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial ripe:concerns ripekg:author/RIPEAU38F1243A568B5291Mansooreh Samimi
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial ripe:concerns ripekg:author/RIPEAUA26EFAAD05CF4C60Mansooreh Samimi
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial ripe:concerns ripekg:author/RIPEAUAEB273847E760D0FFereshteh Bahmani
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial ripe:concerns ripekg:author/RIPEAUC4F4857955665209Hamidreza Jamilian
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial ripe:concerns ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial ripe:concerns ripekg:work/10.1080%2F09513590.2017.1290071
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial ripe:rationale Concerns/Issues About Data;Concerns/Issues about Results and/or Conclusions;Investigation by Journal/Publisher;Original Data and/or Images not Provided and/or not Available;Updated to Retraction
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial ripe:retractionWatchRecordId 67439
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA084C6EAC9724305F-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA084C6EAC9724305F-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA0C83AF9CE6274D42-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA0C83AF9CE6274D42-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA188DF79DAC4D30E2-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA188DF79DAC4D30E2-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA1CF9367F3C1B1AFC-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA1CF9367F3C1B1AFC-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA22B2228793442254-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA22B2228793442254-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA3DB7B5186353EACB-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA3DB7B5186353EACB-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA4BED4D9BD987577D-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA4BED4D9BD987577D-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA533765E11F40F1A0-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA533765E11F40F1A0-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA534C4E03EC302AE0-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA534C4E03EC302AE0-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA55912887A066C004-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA55912887A066C004-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA5D88C2D2406A5D02-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA5D88C2D2406A5D02-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA624ED2A466C40B70-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA624ED2A466C40B70-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA69C9C09037F4A7D7-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA69C9C09037F4A7D7-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA80149EADA6466949-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA80149EADA6466949-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA83B5CB372F4B48C3-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA83B5CB372F4B48C3-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA84BEB5719212517B-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA84BEB5719212517B-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA85E75680E0A580E5-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA85E75680E0A580E5-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA8DB1A5C7D4B2BCF0-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA8DB1A5C7D4B2BCF0-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA95D9EF8B2CE9BCA4-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA95D9EF8B2CE9BCA4-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA9FB7C0468A11295E-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA9FB7C0468A11295E-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEAA8CC2475945829CC-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEAA8CC2475945829CC-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEAC29393890CA84E8D-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEAC29393890CA84E8D-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEAC60164BBD59BB4A3-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEAC60164BBD59BB4A3-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEAF3FB72DC47E629EA-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEAF3FB72DC47E629EA-inspectai-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEAFB2FF36932B98401-human-1-3
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEAFB2FF36932B98401-inspectai-1-3